Compare Enveric Biosciences Inc (ENVB) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Raymond James Financial, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Raymond James Financial, Inc. trades at $180.02 (market cap $34.63B). The key difference: Raymond James Financial, Inc. is far larger — about 5585.5× Enveric Biosciences Inc's market cap, and Raymond James Financial, Inc. pays a 1.2% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | RJF | |
|---|---|---|
Market Cap | $6.20M | $34.63B |
Sector | Health | Financials |
52-Week High | $17.40 | $180.55 |
52-Week Low | $1.27 | $140.89 |
Enterprise Value | $1.30M | — |
Dividend Yield | — | 1.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
